King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Sarah Ramiz
Dr. Sarah Ramiz is Head of the Leukemia / Lymphoma Section and Consultant Pediatric Hematologist-Oncologist, and a leading pediatric oncology specialist in Riyadh, Saudi Arabia. She leads multidisciplinary care for children with acute leukemia, lymphoma, and bone marrow failure syndromes.
- Head — Leukemia/Lymphoma Section (Pediatric Hematology/Oncology), since 2023
- 11–20 years of practice experience in pediatric hematology-oncology
- MD from University of Jordan Faculty of Medicine
- Prior academic appointments at Wayne State University and Central Michigan University, USA
- Adjunct Assistant Professor — Alfaisal University, Riyadh
Qualifications & Credentials
Medical Degrees
- MD — University of Jordan Faculty of Medicine, Amman, Jordan
- Pediatric Residency — Information not publicly available.
- Pediatric Hematology/Oncology Fellowship — Children's Hospital Colorado / Children's Hospital of Michigan, USA
Fellowships & Special Training
- Pediatric Hematology/Oncology Fellowship — Children's Hospital Colorado / Children's Hospital of Michigan, USA
Certifications & Accreditations
- American Board of Pediatrics (Pediatric Hematology/Oncology) — Information not publicly available.
- Saudi Commission for Health Specialties (SCFHS) registration
Areas of Expertise
Major Conditions Treated
- Pediatric Acute Lymphoblastic Leukemia (ALL)
- Pediatric Acute Myeloid Leukemia (AML)
- Hodgkin Lymphoma (pediatric)
- Non-Hodgkin Lymphoma (pediatric)
- Relapsed/Refractory Pediatric Leukemia
- Hemophilia A and B
- Aplastic Anemia
- Sickle Cell Disease
Sub-specialties
- Pediatric Leukemia — Minimal Residual Disease (MRD) Precision Medicine: Section leadership in MRD-guided therapy for pediatric ALL — critical for best childhood leukemia treatment in Saudi Arabia.
- Relapsed/Refractory Leukemia Salvage Therapy: Expertise in clofarabine-based regimens and bridge-to-transplant strategies.
- Pediatric Hemophilia Care: Comprehensive management of bleeding disorders including factor replacement and novel therapies.
Advanced Procedures & Treatments
- Pediatric Leukemia Induction and Consolidation Chemotherapy
- Relapsed/Refractory Salvage Chemotherapy (Clofarabine-based)
- Chemotherapy Port Management and Care
- Intrathecal Chemotherapy for CNS Prophylaxis
- Hemophilia Factor Replacement Therapy
- Blood Product Administration and Transfusion Support
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia — Head of Section, Leukemia/Lymphoma; Consultant, Pediatric Hematology/Oncology (2021–Present)
Past Affiliations
- Children's Hospital of Michigan, Detroit, USA — Pediatric Hematologist-Oncologist
- Children's Hospital Colorado, Denver, USA — Pediatric Hematology/Oncology Fellow
- Central Michigan University, USA — Assistant Professor of Medicine
- Wayne State University, USA — Assistant Clinical Professor of Medicine
Academic & Research Roles
- Adjunct Assistant Professor — Alfaisal University, Riyadh
- Assistant Clinical Professor of Medicine — Wayne State University, USA
- Assistant Professor of Medicine — Central Michigan University, USA
Key Achievements
- Section leadership of a dedicated pediatric leukemia/lymphoma programme at a regional referral centre
- Author on major single-centre clofarabine study in relapsed/refractory pediatric leukemia (43 patients)
- Extensive multi-institutional academic appointments in the USA and Saudi Arabia
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- American Society of Pediatric Hematology/Oncology (ASPHO) — Information not publicly available.
- American Society of Hematology (ASH) — Information not publicly available.
Research & Publications
Published Papers (Selected)
- Ramiz S, Elhaj O, Siddiqui K, Khan S, AlSaedi H, AlAnazi A, Al-Ahmari A, Al-Jefri A, Sahvan O, Ayas M, Ghemlas I. Clofarabine in Pediatric Acute Relapsed or Refractory Leukemia: Where Do We Stand on the Bridge to Hematopoietic Stem Cell Transplantation? J Hematol. 2023;12(1). DOI: 10.14740/jh1065
- Ghemlas I, Al-Ebaid I, Siddiqui K, Al-Ahmari A, Al-Jefri A, Jafri S, Ayas M, Ramiz S, Khan S, AlSaedi H. Post-Induction Minimal Residual Disease in Pediatric Pre-B-Cell ALL: A Step Towards Precision Medicine?
Ongoing Research & Clinical Interests
- Minimal residual disease (MRD) in pediatric ALL
- Relapsed/refractory pediatric leukemia
- Hemophilia management in the MENA region
- Bridge-to-HSCT strategies in children
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (SAR) | Estimated Cost (USD) |
|---|---|---|
| Pediatric Hem-Onc Consultation | SAR 500 – SAR 1,500 | $135 – $400 |
| Pediatric Induction Chemotherapy (full course) | SAR 60,000 – SAR 200,000 | $16,000 – $53,000 |
| Salvage Chemotherapy (Clofarabine-based) | SAR 40,000 – SAR 150,000 | $10,700 – $40,000 |
| Intrathecal Chemotherapy (per session) | SAR 2,000 – SAR 6,000 | $535 – $1,600 |
Frequently Asked Questions
1. What advanced technologies does Dr. Sarah Ramiz use as a Pediatric Oncologist?
Dr. Sarah Ramiz uses advanced pediatric leukemia protocols including MRD-guided precision medicine, clofarabine-based salvage regimens, immunotherapy (Blinatumomab, Inotuzumab), and integration of CAR-T cell therapy for eligible relapsed/refractory ALL patients. International second opinions are available through Cancer Rounds.
2. What conditions does Dr. Sarah Ramiz specialize in treating?
Dr. Sarah Ramiz treats pediatric acute lymphoblastic leukemia, acute myeloid leukemia, Hodgkin and non-Hodgkin lymphomas, relapsed/refractory pediatric leukemia, hemophilia, and other bleeding disorders. She is a senior pediatric hematology-oncology consultant in Riyadh regularly sought by international families for complex leukemia cases.
3. How do I book an appointment with Dr. Sarah Ramiz?
Appointments with Dr. Sarah Ramiz can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Sarah Ramiz?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Sarah Ramiz, including Saudi Arabia medical visa invitation letters, airport transfers, and local accommodation coordination in Riyadh.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation (Arabic, English, and more), financial counselling, and pre-travel virtual consultations to review medical records before arrival in Riyadh.
6. Does Dr. Sarah Ramiz offer second opinions as a Pediatric Oncologist?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with Dr. Sarah Ramiz, an expert Pediatric Oncologist in Riyadh, Saudi Arabia.
